Dosing & Uses
Diabetes Mellitus, Type 2
Subdermal implant pending FDA approval that provides continuous SC delivery of exenatide for months
Next:
Pharmacology
Mechanism of Action
A glucagonlike peptide-1 (GLP-1) that mimics incretin and promotes insulin secretion, suppresses glucagon, and slows gastric emptying
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
